Myelodysplastic Syndrome With Low-grade Lesions

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Myelodysplastic Syndrome With Low-grade Lesions trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT02269592

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Blood cancers occur when the molecules that control normal cell growth are damaged. Many of these changes can be detected by directly examining parts of the can…

United States10,000 participantsStarted 2014-08

All recent trials (2 shown)

CompletedPhase 2

NCT02477631

Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients

The effect oral iron chelator Deferiprone on the Oxidative stress and on Iron Overload status in transfusion dependent, iron-overloaded low risk MDS patients;…

Israel19 participantsStarted 2016-02

Treatment: Deferiprone